Article
SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease…
Diabetes, Metabolic Syndrome and Obesity · 2019 · Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F
Key facts
| Title | SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions |
|---|---|
| First author | Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F |
| Journal | Diabetes, Metabolic Syndrome and Obesity |
| Published | Jul 3, 2019 |
| DOI | 10.2147/DMSO.S212715 |
| Devices mentioned | 212715, K981990 |
| Product codes mentioned | EFB |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1